This phenotype is present both in clinical biospecimens and several mutant KRAS lung cancer lines whose DLC1 protein levels are regulated by activation of the Cullin 4A (CUL-4A) ubiquitin E3 ligase and subsequent proteasome-dependent degradation of DLC1 protein14. This evidence concerns the gene KRAS and lung carcinoma.